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Objective: This study aims to demonstrate our surgical experience for bronchiectasis and analyze the
risk factors related with the surgery outcome.Methods: We retrospectively reviewed medical records of
260 consecutive patients who underwent surgery for bronchiectasis between January 2000 and
December 2010. The factors related with the outcome were analyzed and the candidate factors were
screened by c2 test and t test. Furthermore, logistic regression analysis was used for multiple factor
analysis to obtain the independent factors that affected the surgical outcome. Results: Complications
occurred in 30 (11.5%) patients during perioperative period. The univariate analysis showed that sig-
niﬁcant differences can be observed in age (P ¼ 0.000), sputum volume (P ¼ 0.000), smoking history
(P ¼ 0.033), pulmonary function (P ¼ 0.003), Gram-negative bacillus infection (P ¼ 0.000), bronchial
stump coverage (P ¼ 0.016) using intercostals muscles or pedicle pleura embedding and surgical
approach (P ¼ 0.003) between the patients with excellent and poor outcome. The multivariable analyses
showed that sputum volume (P ¼ 0.000), Gram-negative bacillus infection (P ¼ 0.000) and bronchial
stump coverage (P ¼ 0.000) were the three independent factors related with surgical outcome.
Conclusion: Surgery is an effective treatment option for bronchiectasis. Sputum volumes lower than
30 mL, negative proof of Gram-negative bacteria and bronchial stump coverage using intercostals
muscles or pedicle pleura embedding are the key factors for successful treatment. Special attention has
to be given to any complications in elderly patients.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Bronchiectasis, as a chronic suppurative lung disease, is ﬁrst
described in 1819 by Laenec et al., which is currently deﬁned as
dilation of the bronchi, repeated infection and destruction of the
bronchial wall and lung [1]. The disease arises from a cycle of
inﬂammation and infection [2]. The normal musculoelastic tissueurgery, Shanghai Pulmonary
ad, No. 507 Yangpu District,
ang).
by Elsevier Ltd. All rights reservedand cartilage of the bronchial wall are destroyed, resulting in
ﬁbrosis [3]. Bronchiectasis causes severe pulmonary infections and
loss of lung function, leading to chronic morbidity, and may
contribute to premature mortality [4,5].
In developed countries, the prevalence of bronchiectasis has
decreased and patients in early disease stages could be successfully
treated by conservative procedures [6]. But bronchiectasis is still an
important problem for some serious pulmonary infections in
developing countries [7]. Conservative treatments, such as antibi-
otic treatment, postural drainage and bronchodilators, have been
used to control the symptom, but a mortality of 19e31% still exists
[8]. In addition, surgical resection can alleviate symptoms or.
Table 1
Characteristic of patients.
Number of
patients
Number of
patients
Lesion locations
Single right lobe 70
Multiple right lobes 42
Single left lobe 81
Multiple left lobes 29
Multiple bilateral lobes 38
Surgical approach Left lung Right lung
Pneumonectomy 29 12
Upper lobectomy 41 32
Middle lobectomy 0 34
Lower lobectomy 46 16
Upper and middle lobectomy 0 14
Middle (or lingual) and lower
lobectomy
8 7
Upper and lower lobectomy 2 9
Segmentectomy 6 4
Comorbidities or complications
Lung abscess 95
Pneumonia 78
Damaged lung 26
Aspergillosis infection 24
Broncholithiasis 17
Bullae of lung 15
Pulmonary interstitial ﬁbrosis 3
Kartagener syndrome 2
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applied in the bronchiectasis treatment from the late 1930s [9].
However, complexity of surgical procedure, high rate of post-
operative complications, and few available clinical and follow-up
reports hinder the development in surgical treatment of bronchi-
ectasis [10].
In this study, we retrospectively reviewed clinical data of 260
cases of bronchiectasis and tried to ﬁnd the key factors that affected
the incidence of the complications of bronchiectasis in order to
improve the clinical outcome.
2. Patients and methods
2.1. Patients population
We retrospectively reviewedmedical records of 260 patientswith
surgical resection for bronchiectasis between January 2000 and
December 2010 at the Department of Cardiothoracic Surgery in
Shanghai Pulmonary Hospital. Major clinical symptoms of patients
were recurrent cough or productive cough, including repeated he-
moptysis andobviousmoist rales in lung. Thincomputed tomography
(CT) test for chest was used to evaluate the small airway disease and
bronchoscopewasperformed for lesion test. Patientswereperformed
with microbiologic culture analysis for respiratory tracts and pul-
monary ventilation function tests including forced expiratory volume
in one second (FEV1), forced vital capacity, peak expiratory ﬂow
before surgery. All of the patients assigned the informed consent.
2.2. Preoperative treatment
All patients except 25 patients with signiﬁcant hemoptysis were
assessed by the physician, trained with abdominal respiration and
processed with anti-infection treatment. The 25 patients were
transferred to the surgical emergency. A total of 235 patients were
prescribed with anti-biotic treatment. Among them, 143 (60.9%)
were applied with mono-antibiotic therapy and 92 (39.1%) were
with dual antibiotic therapy. The duration of the anti-biotic treat-
ment was between 7 and 21 days and the average time was 11.5
days. Fifty patients were with mean sputum volume larger than
30 mL before operation and 210 were less than or equal to 30 mL.
The sputum culture results showed that 36 patients (13.8%) were
infected with Gram-negative mycobacteria and 224 (86.2%) not
infected. FEV1 value of the pulmonary function was from 1.45 to
2.89 with a mean of 1.86. The percentages of the FEV1 were from
56% to 110% with a mean of 65%.
2.3. Surgical approach, duration and bleeding volume
Twenty-ﬁve patients with uncontrollable hemoptysis were pro-
cessed with emergency operation and others were processed with
selective operation. The type of surgery was summarized in Table 1.
Among all patients, 233 cases were performedwith bronchial stump
coverage using intercostals muscles or pedicle pleura embedding
and 27 were not performed with bronchial stump coverage. The
operation timewas 2e12hwith an average timeof 4.5 h. The average
blood loss during the operation was 750 mL (50e3200 mL). The
mean volume of blood transfusion was 828 mL (0e4200 mL).
2.4. Postoperative treatment and follow-up
In postoperative treatment, the average indwelling time of the
thoracic duct was 3.5 days (2e8 days). The duration of the anti-
biotic medication was from 5 to 52 days (mean value was 12.8
days). The hospital stay was from 8 to 67 days (mean value was 19.7
days). All patients were followed up in our outpatient clinic.2.5. Data analysis
The risk factors included gender, age, tuberculosis history,
smoke history (including short-term smoking history or long-term
involvement in the second-hand smoke), sputum volume control,
pulmonary function FEV1, Gram-negative Pseudomonas aeruginosa,
and klebsiella pneumonia infection and other common respiratory
tract bacteria infection, bronchial stump coverage, bleeding volume
during operation, and surgical approach. The factors affecting the
surgery efﬁciency were listed and patients were grouped based on
the factors, such as the incidence of complications, the symptoms of
hemoptysis and productive cough in 3 years follow-up and if no
obvious disease foci were observed by CT test, the outcome of the
surgical procedure was considered successful. The relationships
between potential factors and postoperative complications were
assessed by univariate analyses. The risk of poor surgical outcome
was evaluated with forward and backward stepwise logistic
regression analysis to estimate odds ratios (OR) and 95% conﬁdence
intervals (CI). Quantitative variables were compared by t test and
chi-square test. All datawere analyzed using SPSS 17.0 forWindows
(SPSS Inc., Chicago, IL, USA). A value of P  0.05 was considered
statistically signiﬁcant.
3. Results
A total of 260 patients who underwent surgical treatment for
bronchiectasis in our department were included in this study. The
mean age of these patients was 30.2 years. Among them, 163 pa-
tients were female and 97 patients were male. The courses of the
disease were from 1 month to 30 years and 93 (35.8%) of the pa-
tients were more than a decade. Productive cough and recurrent
hemoptysis was found in 135 (51.9%) and 125 (48.1%) patients,
respectively; while there were 38 (14.6%) patients with recurrent
massive hemoptysis (hemoptysis volume was more than 300 mL at
one time or 600 mL in 24 h). Chest CT scan showed that 110 (42.3%)
cases were with disease foci on the left lung; 112 (43.1%) cases were
on the right lung; and 38 (14.6%) cases were on the bilateral lung
(Table 1). The pathological section results conﬁrmed that all
Table 2
Factors associated with postoperative outcome with univariate analysis for
bronchiectasis.
Risk factors Number of patients
with satisﬁed
outcome (n ¼ 223,
%)
Number of patients
without satisﬁed
outcome (n ¼ 37, %)
c2 or t
value
P value
Sex 0.438 0.508
Male 138 (61.9%) 25 (67.6%)
Female 85 (38.1%) 12 (32.4%)
Age 17.940 <0.00001
Youth (<45 years) 126 (56.5%) 7 (18.9%)
Old (45) 97 (43.5%) 30 (81.1%)
Tuberculosis
history
0.174 0.677
Yes 14 (6.3%) 3 (8.1%)
No 209 (93.7%) 34 (91.9%)
Smoking history 4.538 0.033
Yes 134 (60.1%) 29 (78.4%)
No 89 (39.9%) 8 (21.6%)
Gram-negative
bacillus
infection
31.252 <0.00001
Positive 20 (9.0%) 16 (43.2%)
Negative 203 (91.0%) 21 (56.8%)
Sputum volume 28.655 <0.00001
30 192 (86.1%) 18 (48.6%)
>30 31 (13.9%) 19 (51.4%)
Bronchial stump
coverage
5.853 0.016
Yes 204 (91.5%) 29 (78.4%)
No 19 (8.5%) 8 (21.6%)
Pneumonectomy 9.018 0.003
Yes 29 (13.0%) 12 (32.4%)
No 194 (87.0%) 25 (67.6%)
Range Mean T P value
Pulmonary
function
(FEV1%)
1.45e2.89 (56%
e110%)
1.86 3.023 0.003
Bleeding volume
(mL)
50e3200 mL 750 mL 0.012 0.991
Table 3
Variables that adversely affected surgical results with logistic regression analysis for
bronchiectasis.
Variables OR P value 95% CI
Age 1.044 0.032 1.004e1.086
Sputum volume 1.075 <0.00001 1.034e1.117
Smoking history 1.999 0.272 0.581e6.880
Gram-negative bacillus infection 27.929 <0.00001 8.044e96.971
Pulmonary function (FEV1%) 0.988 0.486 0.956e1.022
Bronchial stump coverage 0.027 <0.00001 0.006e0.129
Pneumonectomy 2.210 0.245 0.581e8.408
OR, odds ratios; CI, conﬁdence intervals.
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them, 85 (32.7%) cases were with cystic bronchiectasis; 42 (16.2%)
cases were with cylindrical bronchiectasis; and 123 (47.3%) cases
were with mixed bronchiectasis.
Complications occurred in 30 (11.5%) patients during perioper-
ative period. Two patients were dead postoperatively and both of
them were processed with emergency pneumonectomy, one of
whom was diagnosed as pulmonary embolism and one was acute
arrhythmia. Eight patients with acute respiratory failure got better
when 3 patients were ventilated with non-invasive ventilator and 5
were processed with endotracheal intubation or mechanical
ventilation. Atelectasis occurred in 9 (3.5%) patients who got better
after ﬁberbronchoscope suction for once or several times. Bron-
chopleural ﬁstul and empyemawere observed in 11 (4.2%) patients,
among whom 6, 3 and 2 patients were performed with right, left
pneumonectomy and lobectomy, respectively. Bronchial stump
suture through thoracotomywas processed in 3 patients. Four cases
underwent thoracic closed drainage and 4 cases underwent dres-
sing change in the chest and stufﬁng operation by muscle segment.
Follow-up data were obtained from 255 (98.1%) patients. The
mean follow-up time of these patients was 6.7 years (range from 3
to 10 years). The symptoms disappeared in 199 (76.5%) patients,
and 52 (20.0%) patients showed occasional symptoms with cough
or frothy sputum but did not show recurrent hemoptysis or yellow
phlegm. A total of 7 (2.7%) patients showed small amount of
recurrent hemoptysis and yellow phlegm, among whom 2 were
operated with left lower lobectomy; 2 with right lower lobectomy;
3 with left lingular segment of the lung and lower lobe lobectomy.
There were 5 deaths in 2e7 years of follow-up period, among
whom 3 died from pulmonary heart disease, 2 from kidney failure
and 1 from unknown reason.
Univariate analysis results showed that there were signiﬁcant
differences in age (P < 0.00001), sputum volume (P < 0.00001),
smoking history (P ¼ 0.033), pulmonary function (P ¼ 0.003),
Gram-negative bacillus infection (P < 0.00001), bronchial stump
coverage (P¼ 0.016) and surgical approach (P¼ 0.003) between the
patients with excellent and poor outcome (Table 2). The multivar-
iable analyses showed that age (95% CI ¼ 1.004e1.086, P ¼ 0.032),
sputumvolume (95% CI¼ 1.034e1.117, P < 0.00001), Gram-negative
bacillus infection (95% CI ¼ 8.004e96.971, P < 0.00001) and
bronchial stump coverage (95% CI ¼ 0.006e0.129, P < 0.00001)
were the four independent factors related with surgical outcome
(Table 3).
4. Discussion
Although the advances in thoracic surgery, the optimal treat-
ment for bronchiectasis is still in controversy [11]. In the present
study, all 260 bronchiectasis patients with medical treatment
duration for long time were still accompanied with primary or
secondary abscess, organized pneumonia and broncholithiasis,
thus requiring surgical treatment. We performed selective surgery
for 235 patients and emergency surgery for 25 patients with un-
controllable massive hemoptysis.
In the present study, incidence of postoperative complications
was 11.5% as previous study that the incidence and mortality in
bronchiectasis treatment with surgery were 9.4%e24.6% and 0%e
8.3%, respectively [12]. The higher incidence of postoperative
complications and mortality may be due to two reasons. First, the
weaker physical condition of bronchiectasis patients increased the
risk of postoperative infection. Second, emergency operation and
insufﬁcient preoperative preparation happened in some patients
due to uncontrollable massive hemoptysis. For the ﬁrst reason, we
assessed the patients' conditions, instructed the patients with
respiratory training and anti-biotic treatment, and used nutritionsupport. For the second reason, emergency operation should be
avoided if there was no sufﬁcient time for surgery preparation.
Univariate analysis results showed that age, sputum volume,
Gram-negative bacillus infection and bronchial stump coverage
were related with the outcome and prognosis. Miyako Hiramatsu
et al. showed that an immunocompromised status, P. aeruginosa
infection, and the extent of residual bronchiectasis were signiﬁ-
cantly related with the shorter relapse-free interval by univariate
analysis [8]. Age was one of the factors that affected the compli-
cations after operation, which was consistent with the previous
result [13]. In young patients, the disease duration was shorter and
irreversible lesions were lighter than that in old ones who were
accompanied by physical deterioration, hypertension, pulmonary
heart disease and renal insufﬁciency. Thus, the risk of surgery was
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age of patients. For the old patients, various organs should be
examined to assess the risk before operation.
Massive sputum and pulmonary infection are the most common
symptoms in bronchiectasis patients and sputum volume repre-
sents the severity of the pulmonary infection [4,14]. The patients
who have more sputum volume and larger scope of pulmonary
infection are inclined to have postoperative complications. Bilateral
or multiple lobes disease is present in several patients with bron-
chiectasis. If the preoperative infection control fails, infection foci
would induce bronchial secretion drainage obstruction and sputum
accumulation, eventually leading to atelectasis and pulmonary
infection. With the ability to clean the intra-tracheal secretion and
decrease the sputum volume in airway or sputum accumulation in
the pulmonary bronchia, postural drainage is critical for infection
control [15]. Most of the Gram-negative bacteria are conditional
pathogen and are common in hypoimmunity patients with
emphysema, bronchiectasis and lung cancer [16e18]. Gram-
negative bacterial infection could lead to severer pulmonary in-
fections and other complications in perioperative period. Therefore,
sputum culture analysis is urgently needed before operation, which
could provide reference for assessing the incidence of post-
operative complications. Patients should be treated with antibiotics
and were performed with surgery after negative proof of Gram-
negative bacillus.
In the current study, bronchopleural ﬁstula and secondary em-
pyema were found in 11 patients, which might result in severe
complications, such as air leakage, empyema of operative side and
pulmonary infections. According to the previous reports [19e22],
bronchial stump with autologous tissue is related with incidence of
the bronchopleural ﬁstula, which is consistent with our results.
Therefore, the bronchial stump coverage should be performed to
reduce the incidence of complication after pneumonectomy in the
bronchiectasis patients. Furthermore, bronchial stump coverage
should be carried out under adequate blood supply and with liga-
tion rather than electronic scalpel to stop bleeding in case of
destroying the bronchial wall. Finally, bronchial stump coverage
was performed using intercostals muscles or pedicle pleura
embedding.
The primary limitation of the study is its retrospective nature.
The retrospective nature of the study cannot account for the un-
known variables affecting the outcome that are not correlated
strongly with measured variables. Despite the retrospective and
observational nature of the study, we provided data on a large
cohort of patients undergoing surgery to treat bronchiectasis
which has not been reported before, and demonstrated the safety
and efﬁcacy of surgical intervention for treating this pathology.
Lastly, we admit the fact that our study has emanated from a
single institution. Undoubtedly, any validation of the ﬁndings will
require further prospective preferably randomized multicenter
studies.
In conclusion, we found that surgery treatment was an effec-
tive way to cure the bronchiectasis in selective patients, and the
surgery decision should be made after the evaluation of the res-
piratory physician. As age was one of the factors that impacted
surgery, special attention must be paid to the management of
elderly patients in a specialized center. Sputum volume lower than
30 mL, negative proof of Gram-negative bacillus infection, and
bronchial stump coverage are key factors for effective surgery
treatment.Ethical approval
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